Exchange: NASDAQ·Updated 07:30 PM EDT

SLDB News

News
all
press releases
Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday
Wall Street analysts changed outlook on top names: Evercore raised Salesforce target, Needham raised Nutanix target, Ascendiant raised PAVmed target, Cantor raised Okta target, Piper raised Veeva target, Cantor boosted Solid Biosciences target, BTIG raised Crowdstrike target, Cantor cut Dycom...
Benzinga
More News
Capricor Says FDA Used 'Obsolete' Analysis In Deramiocel Review – CAPR Stock Plummets After Agency Released Briefing Document
The FDA released briefing documents, raising concerns over whether Capricor’s lead therapy, Deramiocel, has demonstrated sufficient effectiveness in treating cardiomyopathy in patients with Duchenne muscular dystrophy.
Stocktwits
Where Will Solid Biosciences Inc (SLDB) Stock Be in the Next 12 Months?
Where Will Solid Biosciences Inc (SLDB) Stock Be in the Next 12 Months...
Yahoo! Finance: News
Solid Biosciences (NASDAQ:SLDB) Rating Increased to Strong-Buy at Truist Financial
Truist Financial raised shares of Solid Biosciences to a "strong-buy" rating in a research note on Monday...
MarketBeat
Solid Biosciences (NASDAQ:SLDB) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen lowered shares of Solid Biosciences from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the stock...
MarketBeat
Solid Biosciences (NASDAQ:SLDB) Sets New 12-Month High - Here's What Happened
Solid Biosciences (NASDAQ:SLDB) Hits New 12-Month High - What's Next...
MarketBeat
Solid Biosciences (NASDAQ:SLDB) Stock Price Down 3.9% - Here's Why
Solid Biosciences (NASDAQ:SLDB) Stock Price Down 3.9% - What's Next...
MarketBeat
Solid Biosciences (NASDAQ:SLDB) Raised to "Hold" at Wall Street Zen
Wall Street Zen raised Solid Biosciences from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
Solid Biosciences (NASDAQ:SLDB) Trading 6.4% Higher - Here's What Happened
Solid Biosciences (NASDAQ:SLDB) Shares Up 6.4% - Here's What Happened...
MarketBeat

Advertisement|Remove ads.